SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-061627
Filing Date
2019-03-04
Accepted
2019-03-04 07:11:02
Documents
1
Period of Report
2019-03-04
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d715878d8k.htm 8-K 19031
  Complete submission text file 0001193125-19-061627.txt   20079
Mailing Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014
Business Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014 502-241-4114
Apellis Pharmaceuticals, Inc. (Filer) CIK: 0001492422 (see all company filings)

IRS No.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38276 | Film No.: 19651856
SIC: 2834 Pharmaceutical Preparations